search button

Expression of phosphorylated extracellular signal‑regulated kinase at the invasive front of hepatic colorectal metastasis

  • Authors:
    • Hyun‑Soo Kim
    • Sung‑Im Do
    • Byeong-Joo Noh
    • Young In Jeong
    • Sun Jin Park
    • Youn Wha Kim

  • View Affiliations

  • Published online on: January 14, 2015     https://doi.org/10.3892/ol.2015.2874
  • Pages: 1261-1265
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Raf‑1 kinase inhibitory protein (RKIP), an endogenous inhibitor of the extracellular signal‑regulated kinase (ERK) pathway, suppresses metastasis in a number of cancer types, including colorectal carcinoma (CRC); thus, RKIP downregulation significantly contributes to CRC invasiveness and metastatic potential. However, our previous study demonstrated that RKIP‑positive tumors in CRC patients are predictive of hepatic colorectal metastases (HCMs). Based on the previous finding that the ERK pathway can be activated independently of RKIP, we hypothesized that RKIP‑expressing HCMs may express significant levels of phosphorylated ERK (pERK). Thus, the present study evaluated the expression of RKIP and pERK in 68 HCM tissue samples using immunohistochemistry. RKIP expression was positive in 22 (32.4%) of the 68 samples, seven (31.8%) of which exhibited nuclear pERK immunoreactivity exclusively at the invasive tumor front. Furthermore, pERK expression at the invasive front was significantly associated with recurrent HCM following hepatic resection, and pERK expression observed at the invasive front of RKIP‑expressing HCMs indicated that the activation of the ERK pathway may also be involved in the invasive process of these tumors, despite the presence of RKIP. A strong association between pERK expression and the presence of recurrent HCM may indicate that the ERK pathway is important in the metastatic recurrence of RKIP‑positive HCM.
View Figures
View References

Related Articles

Journal Cover

March-2015
Volume 9 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Kim HS, Do SI, Noh B, Jeong YI, Park SJ and Kim YW: Expression of phosphorylated extracellular signal‑regulated kinase at the invasive front of hepatic colorectal metastasis. Oncol Lett 9: 1261-1265, 2015
APA
Kim, H., Do, S., Noh, B., Jeong, Y.I., Park, S.J., & Kim, Y.W. (2015). Expression of phosphorylated extracellular signal‑regulated kinase at the invasive front of hepatic colorectal metastasis. Oncology Letters, 9, 1261-1265. https://doi.org/10.3892/ol.2015.2874
MLA
Kim, H., Do, S., Noh, B., Jeong, Y. I., Park, S. J., Kim, Y. W."Expression of phosphorylated extracellular signal‑regulated kinase at the invasive front of hepatic colorectal metastasis". Oncology Letters 9.3 (2015): 1261-1265.
Chicago
Kim, H., Do, S., Noh, B., Jeong, Y. I., Park, S. J., Kim, Y. W."Expression of phosphorylated extracellular signal‑regulated kinase at the invasive front of hepatic colorectal metastasis". Oncology Letters 9, no. 3 (2015): 1261-1265. https://doi.org/10.3892/ol.2015.2874